Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BICO Group ABCLLKF 63 Equity-to-Asset is 0.54 as of Mar. 2026, which is 21% below its 10-year median of 0.68. GuruFocus rates CLLKF with a GF Score™ of 63/100 and a GF Value™ of $3.68 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 852 Medical Devices & Instruments companies, BICO Group AB ranks worse than 62.91% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BICO Group AB's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $172.7 Mil. BICO Group AB's Total Assets for the quarter that ended in Mar. 2026 was $318.8 Mil.
Therefore, BICO Group AB's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.54.
The historical rank and industry rank for BICO Group AB's Equity-to-Asset or its related term are showing as below:
CLLKF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.4 Med: 0.68 Max: 0.96
Current: 0.54
During the past 10 years, the highest Equity to Asset Ratio of BICO Group AB was 0.96. The lowest was 0.40. And the median was 0.68.
CLLKF's Equity-to-Asset is ranked worse than 62.91% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.645
vs CLLKF: 0.54
BICO Group AB (OTCPK:CLLKF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
BICO Group AB Equity-to-Asset Related Terms
BICO Group AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for BICO Group AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLLKF vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, BICO Group AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BICO Group AB Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where BICO Group AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
BICO Group AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BICO Group AB (CLLKF) has a Equity-to-Asset of 0.54 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on BICO Group AB and its competitors. This is 21% below median its historical median of 0.68. Over the past decade, BICO Group AB's Equity-to-Asset has ranged from 0.40 to 0.96. According to the industry distribution chart, BICO Group AB ranks #536 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 62.9%.
Is BICO Group AB's Equity-to-Asset too high?
BICO Group AB's current Equity-to-Asset of 0.54 is 21% below median its 10-year median of 0.68. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 0.96. The Medical Devices & Instruments industry median Equity-to-Asset is 0.65. BICO Group AB's value of 0.54 is 16.3% below this industry median. Based on the distribution chart, BICO Group AB ranks #536 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, BICO Group AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BICO Group AB ranks #536 out of 852 companies for Equity-to-Asset. This places BICO Group AB in the lower half of its industry. The industry median Equity-to-Asset is 0.65. BICO Group AB's value of 0.54 is 16.3% below this benchmark. Historically, BICO Group AB's own Equity-to-Asset has ranged from 0.40 to 0.96 over the past decade. While the company's 10-year median is 0.68 vs. the industry median of 0.65, BICO Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.65, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BICO Group AB's current Equity-to-Asset of 0.54 is 16.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on BICO Group AB and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BICO Group AB's current Equity-to-Asset is 0.54, which is 21% below median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
Based on GuruFocus' analysis, BICO Group AB (CLLKF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.68, compared to a current price of $1.53 — trading 58.4% below its estimated fair value. The current Equity-to-Asset is 0.54, which is 21% below median its 10-year median of 0.68 and 16.3% below the Medical Devices & Instruments industry median of 0.65. BICO Group AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For BICO Group AB (CLLKF), the current Equity-to-Asset is 0.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (CLLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of $1.53 is trading 58.4% below its estimated GF Value™ of $3.68.
GuruFocus considers BICO Group AB to be Possible Value Trap.
Key valuation signals for CLLKF:
Equity-to-Asset: 0.54 (21% below median its 10-year median of 0.68)
GF Value™: $3.68 vs. price of $1.53 (58.4% below fair value)
Industry Position: 16.3% below the Medical Devices & Instruments median (#536 of 852)
No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
63GF Score
Get the complete analysis for CLLKF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLLKF has been successfully added to your 
